Dizzy When You Stand Up? Your Genes May Be Dysregulating Blood Pressure.

MTHFR is an enzyme that catalyzes the conversion of folate into methylfolate, the active form your cells actually use. This active form is essential for producing and recycling nitric oxide, a critical signaling molecule that tells your blood vessels to relax and dilate.

The C677T variant, carried by roughly 40% of people with European ancestry, reduces MTHFR enzyme efficiency by 40 to 70%. This means your cells are struggling to produce adequate methylfolate, and as a result, your nitric oxide production is compromised, leaving your blood vessels less responsive to position changes. Your vessels can’t dilate quickly enough when you stand, so blood pools in your legs and your blood pressure drops.

When you have this variant, standing up feels like your blood pressure can’t catch up with gravity. The room spins, your vision narrows, and you feel a sudden wave of lightheadedness. It’s especially pronounced in the morning, after lying flat, or when you’ve been sitting for a while. Adding extra salt and water helps a little, but it doesn’t address the root problem: your vessels aren’t relaxing and contracting efficiently.

NOS3 encodes endothelial nitric oxide synthase, the enzyme that produces nitric oxide in the lining of your blood vessels. Nitric oxide is the primary signal that tells blood vessels to dilate and increase blood flow. When you stand, your body needs to instantly increase blood flow to your brain and upper body to compensate for gravity pulling blood downward.

The Glu298Asp variant in NOS3, present in roughly 30 to 40% of the population, reduces the amount of functional nitric oxide synthase enzyme produced. This means your blood vessels have a harder time generating the nitric oxide signal they need to dilate rapidly when you change position. Your cardiovascular system has a slower response time, and that delay translates directly into dizziness.

With this variant, you experience a lag between standing and your body’s ability to compensate. The blood pressure drop happens, your vision darkens, and by the time your vessels dilate enough to restore flow, you’ve already felt the symptoms. Physical exertion, heat, or dehydration makes it worse because the demand for rapid vascular adjustment increases.

ACE encodes angiotensin-converting enzyme, a critical part of your renin-angiotensin-aldosterone system (RAAS), the hormonal cascade that maintains blood pressure minute to minute. When you stand, your RAAS activates to constrict blood vessels and increase blood volume awareness, helping your body compensate for gravitational blood pooling.

The ACE Insertion/Deletion (I/D) polymorphism determines how much ACE protein is produced. The D allele (deletion), carried by roughly 35 to 40% of people, is associated with higher ACE activity. Higher ACE activity can lead to excessive vasoconstriction and impaired local vasodilation, creating a dysregulated blood pressure response. Your system overcorrects, constricting vessels when they should be relaxing, or the regional adjustments become uncoordinated.

You might notice your dizziness is worse on certain days, correlated with salt intake or stress levels, because your RAAS is hypersensitive. You might also experience palpitations or feel like your heart is working too hard to maintain blood pressure. Your blood pressure readings might be erratic, normal one moment and elevated the next.

COMT encodes catechol-O-methyltransferase, an enzyme that breaks down dopamine, norepinephrine, and epinephrine. These neurotransmitters are central to your autonomic nervous system, which controls heart rate, blood vessel constriction, and the coordinated adjustments your body makes during position changes.

The Val158Met variant, present in roughly 25% of people homozygous for the slow-metabolizing allele, means you clear dopamine more slowly. Slower dopamine clearance can lead to excessive sympathetic activation (overstimulation of the fight-or-flight response), which dysregulates the fine-tuned autonomic adjustments needed for orthostatic compensation. Your body overshoots in one direction, then undershoots, creating erratic blood pressure swings.

With slow COMT, you might feel jittery or anxious when you stand, experience heart palpitations, or notice that caffeine makes your dizziness worse. Your blood pressure might spike before it drops. You might also feel more sensitive to stimulants and high-stress situations, both of which amplify orthostatic symptoms.

SLC6A4 encodes the serotonin transporter (SERT), the protein responsible for recycling serotonin from the synapse back into the nerve ending. Serotonin is a major regulator of parasympathetic tone (your rest-and-digest system), and it also modulates the baroreceptor reflex, the automatic mechanism that detects pressure changes and triggers compensatory cardiovascular adjustments.

The 5-HTTLPR short allele, carried by roughly 40% of the population, reduces serotonin transporter expression. Reduced SERT function means serotonin accumulates and can overstimulate parasympathetic tone, blunting the sympathetic activation needed for rapid blood pressure compensation. Your body’s ability to quickly increase heart rate and vasoconstriction when standing is dampened.

With this variant, standing up feels like your parasympathetic system (which wants you calm and resting) is competing with your sympathetic system (which needs to activate for the postural change). The result is sluggish, delayed compensation. You might feel fatigued or have brain fog along with the dizziness. Some people report that SSRIs (which further increase serotonin) make their orthostatic symptoms worse.

VDR encodes the vitamin D receptor, a protein that binds active vitamin D (calcitriol) and enables your cells to respond to its signaling. Vitamin D is not just a nutrient for bone health, it’s a hormone that regulates immune function, endothelial function, vascular calcification, and blood pressure regulation through multiple mechanisms including nitric oxide production and RAAS modulation.

The FokI polymorphism in VDR determines the length of the receptor protein, and the shorter isoform (ff genotype), present in roughly 35 to 40% of people depending on ancestry, is more transcriptionally active but may be more sensitive to dysregulation. Certain VDR variants are associated with impaired endothelial function and dysregulated vascular responses, particularly in the context of vitamin D insufficiency. Your blood vessels have a harder time responding appropriately to positional demands.

If you have a VDR variant and low vitamin D status (which is common), your endothelial cells lack the signaling support they need to produce nitric oxide or regulate blood vessel tone. Standing up becomes a more challenging cardiovascular event. Your symptoms might improve seasonally (better in summer when sun exposure is higher) or vary with vitamin D supplementation status.